Body mass index and response to abatacept in rheumatoid arthritis.

about

A critical role of pentraxin 3 in severe sepsis and septic shock.Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

P2860

Q48317284-51281896-F72A-4C0A-BFD2-8B189C49C465 Q51013068-2C195442-8820-488F-924E-41345B6B1A07

P2860

Body mass index and response to abatacept in rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q39296233

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Body mass index and response to abatacept in rheumatoid arthritis.

@en

Body mass index and response to abatacept in rheumatoid arthritis.

@nl

type

Item

label

Body mass index and response to abatacept in rheumatoid arthritis.

@en

Body mass index and response to abatacept in rheumatoid arthritis.

@nl

prefLabel

Body mass index and response to abatacept in rheumatoid arthritis.

@en

Body mass index and response to abatacept in rheumatoid arthritis.

@nl

P1476

Body mass index and response to abatacept in rheumatoid arthritis.

@en

P2093

Alain Meyer

http://www.w3.org/2001/XMLSchema#string

Anais Gardette

http://www.w3.org/2001/XMLSchema#string

Elisabeth Palazzo

http://www.w3.org/2001/XMLSchema#string

Francis Berenbaum

http://www.w3.org/2001/XMLSchema#string

Jean Sibilia

http://www.w3.org/2001/XMLSchema#string

Jérémie Sellam

http://www.w3.org/2001/XMLSchema#string

Sébastien Ottaviani

http://www.w3.org/2001/XMLSchema#string

P2860

Adipocytokines: mediators linking adipose tissue, inflammation and immunity

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Body mass index influences the response to infliximab in ankylosing spondylitis

Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.

Effect of obesity on the pharmacokinetics of drugs in humans.

Obesity in rheumatoid arthritis.

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012.

Body weight, gender and response to TNF-α blockers in axial spondyloarthritis.

Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis.

P304

1048-1052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECI.12691

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Philippe Dieudé

Frédéric Lioté

Bruno Fautrel

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27736006

http://www.w3.org/2001/XMLSchema#string

Body mass index and response to abatacept in rheumatoid arthritis.

about

P2860

P2860

Body mass index and response to abatacept in rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698